Related Experiment Video
Updated: Mar 22, 2026

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024
Melanoma exosomes enable tumor tolerance in lymph nodes
1University of Louisville, Department of Pharmacology and Toxicology and the James Graham Brown Cancer Center, Clinical and Translational Research Building, 505 South Hancock Street, Louisville, KY 40202, United States.
Melanoma exosomes may promote tumor tolerance in lymph nodes. This study explores how melanoma exosomes induce vascular endothelial cells to produce TNF-α, leading to lymphatic endothelial cells causing immune tolerance.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Melanoma metastasis commonly involves lymph nodes.
- Melanoma exosomes are known to induce angiogenesis and immune suppression.
- The role of melanoma exosomes in promoting lymph node tumor tolerance is unexplored.
Purpose of the Study:
- To investigate the hypothesis that melanoma exosomes induce vascular endothelial cell (VEC)-derived tumor necrosis factor alpha (TNF-α).
- To determine if TNF-α leads to lymphatic endothelial cell (LEC)-mediated tumor tolerance.
- To explore the mechanism of melanoma exosome-induced tumor tolerance within lymph nodes.
Main Methods:
- Utilizing a fluorescent exosome lymph node trafficking model.
- Conducting ex vivo experiments with lymph node-associated VECs, LECs, dendritic cells, and T lymphocytes.
- Analyzing the interactions between melanoma exosomes, VECs, LECs, and immune cells.
Main Results:
- Proposed experiments aim to demonstrate VEC activation by melanoma exosomes.
- Hypothesized pathway involves VEC-derived TNF-α signaling to LECs.
- The study anticipates findings supporting LEC-mediated immune tolerance induction.
Conclusions:
- Melanoma exosomes may actively shape the lymph node microenvironment to promote immune evasion.
- Understanding this mechanism could reveal novel therapeutic targets for melanoma treatment.
- Further research is warranted to validate the proposed exosome-mediated tolerance pathway.
More Related Videos
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy